Boston Partners
TMDX icon

Boston Partners’s Transmedics TMDX Stock Holding History

Boston Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,553
Closed -$300K – 761
2022
Q2 		$300K Sell
9,553
-9,258
-49% -$247K ﹤0.01% 651
2022
Q1 		$507K Buy
18,811
+2,251
+14% +$40.3K ﹤0.01% 620
2021
Q4 		$317K Buy
+16,560
New +$415K ﹤0.01% 642
2020
Q1 		– Sell
-10,675
Closed -$203K – 747
2019
Q4 		$203K Buy
10,675
+6,622
+163% +$122K ﹤0.01% 641
2019
Q3 		$96K Buy
+4,053
New +$97.2K ﹤0.01% 667

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Boston Partners's TMDX Position: Q3 2022 in Review

Boston Partners sold out of Transmedics (TMDX) in Q3 2022, closing a stake of 9,553 shares — an estimated $300K sold.

Boston Partners first reported a position in TMDX in Q3 2019 and held it in 5 quarters. The position peaked at $507K in Q1 2022. 178 funds tracked by Wall St. Rank hold TMDX as of Q3 2022.

  • Boston Partners reported no remaining Transmedics position as of Q3 2022 after selling out during the quarter.
  • Boston Partners sold 9,553 Transmedics shares in Q3 2022, an estimated $300K.
  • Boston Partners first reported a position in Transmedics in Q3 2019 and held it in 5 quarters.
  • Boston Partners's Transmedics position peaked at $507K in Q1 2022.
  • 178 funds tracked by Wall St. Rank held Transmedics as of Q3 2022.

Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.